03.09.2024 • NewsEvonikDL-methionineinvestment

Evonik Completes Expansion of Methionine Production in Singapore

Evonik has completed the expansion of its MetAmino (DL-methionine) production facilities in Singapore and the production on Jurong Island is again running at full capacity, after shutdowns in the fourth quarter of 2023 and the second quarter of 2024.

The production capacity has been increased by 40,000 metric tons, bringing the total to 340,000 metric tons per year, the company said.

According to Evonik, it has optimized its methionine production plants through process intensification, generating a surplus of steam that is used to produce on-site electricity.

Linde, one of Evonik's partners on Jurong Island, has designed, constructed, and is operating a 9-MW alkaline electrolyzer plant at the site that enables Evonik to use green hydrogen required for the MetAmino production, thus reducing its environmental impact.

“Our collaboration with Linde on the implementation of green hydrogen in our Singapore facilities is a testament to our commitment to sustainability. We work closely with our partners to build a more sustainable future," commented Harald Schwager, deputy chairman of Evonik’s executive board.

Evonik's DL-methionine plants in Singapore have reduced the product carbon footprint of MetAmino at this site by 6% compared to before the expansion, the company stated.

Gaetano Blanda, head of Evonik’s Animal Nutrition business line, said: “We are committed to reducing emissions in line with the latest climate science, and consequently, we have a long-term ambition to expand our targets to align with a 1.5°C warming pathway, and reach net-zero emissions by 2050.”

MetAmino is used in livestock farming for feeding animals.

© RubyMirriam/Getty Images
© RubyMirriam/Getty Images

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.